SARS-CoV-2-specific ELISA development
Vicky Roy, Stephanie Fischinger, Caroline Atyeo, Matthew D. Slein, Carolin Loos, Alejandro B. Balazs, Corinne Luedemann, Michael G. Astudillo, Diane Yang, Duane R. Wesemann, Richelle C. Charles, A. John Lafrate, Jared Feldman, Blake M. Hauser, Timothy M. Caradonna, Tyler E. Miller, Mandakolathur R. Murali, Lindsey R. Baden, Eric J. Nilles, Edward T. Ryan, Douglas A. Lauffenburger, Wilfredo Garcia Beltran, Galit Alter
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyBiologyImmune systemPopulationImmunityMiddle East respiratory syndrome coronavirusAntibodyImmunologyCoronavirus disease 2019 (COVID-19)VirusCoronavirusViral loadMedicineDiseaseInfectious disease (medical specialty)PathologyEnvironmental healthSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies